These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1239751)

  • 1. The influence of phentolamine on the central activity of 5-hydroxytryptamine in rat.
    Kleinrok Z; Jagiello-Wójtowicz E; Sieklucka M
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):99-106. PubMed ID: 1239751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central action of intraventricularly (ivc) administered propranolol and phentolamine in rat.
    Kleinrok Z; Ksiazek A; Przesmycki K; Kolasa K
    Pol J Pharmacol Pharm; 1975; 27(4):405-12. PubMed ID: 1166021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 5-hydroxytryptamine given IVC on rat behaviour.
    Drybański Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):83-8. PubMed ID: 1208232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of 6-hydroxytryptamine in rats.
    Jamrozik-Kruk Z; Brus R
    Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):287-95. PubMed ID: 4859523
    [No Abstract]   [Full Text] [Related]  

  • 8. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of drugs affecting beta-adrenergic receptor. II. The central action of intraventricularly applicated propranolol in rats.
    Ksiazek A; Kleinrok Z
    Pol J Pharmacol Pharm; 1974; 26(3):297-304. PubMed ID: 4859243
    [No Abstract]   [Full Text] [Related]  

  • 10. Central effects of octopamine administered into the lateral ventricle of rats.
    Kleinrok Z; Jagiełło-Wójtowicz E; Szkilnik E
    Acta Physiol Pol; 1979; 30(4):445-53. PubMed ID: 228526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central action of drugs acting on the cholinergic muscarinic receptor. II. Influence of ecothiopate administered into the lateral cerebral ventricle on behavior in rats.
    Kleinrok Z; Wielosz M; Przegaliński E
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):477-84. PubMed ID: 1172420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The central action of intraventricular 5-hydroxytryptamine in the rat (author's transl)].
    Kleinrok Z; Jagiello-wójtowicz E
    Ann Univ Mariae Curie Sklodowska Med; 1975; 30():277-83. PubMed ID: 1241762
    [No Abstract]   [Full Text] [Related]  

  • 15. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central action of glaucine in rodents.
    Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
    Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term erythrosine B-induced inhibition of the brain regional serotonergic activity suppresses motor activity (exploratory behavior) of young adult mammals.
    Dalal A; Poddar MK
    Pharmacol Biochem Behav; 2009 Jun; 92(4):574-82. PubMed ID: 19264092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of compound WA-335 on the central nervous system.
    Maj J; Baran L; Sowińska H; Gancarczyk L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.